Andrew, Peter Michael

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2014

2014

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (May 2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Gastroenterology, 146(5), p. 239. Elsevier

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, J; Slack, Emma; Patuto, Nicola; Cahenzli, Julia; McCoy, Kathleen; Macpherson, Andrew (February 2014). CD62L (L-selectin) shedding for assessment of functional blockade of TNF alpha in anti-TNF treated IBD patients: clinical feasibility and perspectives (DOP060). Journal of Crohn's & Colitis, 8(Suppl1), pp. 43-44. Elsevier 10.1016/S1873-9946(14)60085-4

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, F.; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-selectin) shedding for assessment of functional blockade of TNF alpha in anti-TNF treated IBD patients: clinical feasibility and perspectives. United European Gastroenterology Journal, 2(1suppl), A45-A46. Sage

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Swiss medical weekly, 144(Suppl206), 3S-3S. EMH Schweizerischer �rzteverlag

Provide Feedback